A U.S. District Court in New York sided, in part, with secondary wholesalers, granting their request to halt implementation of the FDA’s drug pedigree regulations or so-called “final rule.”

In December, a U.S. District Court in New York sided, in part, with secondary wholesalers, granting their request to halt implementation of the FDA’s drug pedigree regulations or so-called “final rule.” To read the court order, click here.

This entry was posted in dangerous-doses-impact. Bookmark the permalink.